Predigen News
- Oct 23, 2019
- 1 min read

Ephraim L. Tsalik, MD, MHS, PhD, on ID Host Response Biomarkers

In this podcast, Ephraim L. Tsalik, MD, MHS, PhD, discusses the biomarkers in the pipeline for diagnosing infectious diseases, including tuberculosis and sepsis, and details which ones are most likely to make it to clinical practice.

Ephraim L. Tsalik, MD, MHS, PhD, is an associate professor of medicine, an associate professor in the Department of Molecular Genetics and Microbiology, and a member of the Duke Center for Applied Genomics and Precision Medicine at Duke University in Durham, North Carolina.

Disclosures: BioFire: Grant/Research Support Biomerieux: Grant/Research Support CytoVale: Consultant Immunexpress: Consultant Predigen, Inc.: Officer or Board Member, Research Grant Qvella: Other Financial or Material Support, Research Collaboration

Recent Posts

See All

Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critic

Biomeme and long-time collaborator, Predigen, have entered an agreement to merge in order to expand Biomeme's diagnostic capabilities. Combining Predigen's extensive years of host response research wi

Blood-based test IDs viral infection before symptoms appear

By Meg Bryant for BioWorld September 25, 2020 A team of scientists at Duke Health has identified biomarkers that accurately detect viral infections before a person becomes symptomatic. The findings,

Blood-based Host Response Test Predicts Respiratory Viral Infection in Pre-symptomatic Patients

Study Reveals Blood-based Host Response Test Can Accurately Predict Respiratory Viral Infection in Pre-symptomatic Patients Predigen Developing Diagnostic Tools Designed to Help Physicians Differentia